Table 3 Medium components for the culture of organoids derived from the human FRT and placenta.
From: Organoid systems to study the human female reproductive tract and pregnancy
Type | Expansion medium componentsa | Differentiation medium components | Reference |
|---|---|---|---|
Ovarian | Wnt CM, RSPO1 CM, Noggin, Nicotinamide, EGF, A83-01, Heregulinβ-1, Y-27632, Forskolin, Hydrocortisone, β-Estradiol | – | [69] |
Fallopian Tube | Wnt3A CM, RSPO1 CM, Noggin, Nicotinamide, EGF, FGF10, Y-27632, SB431542 | β-estradiol, progesterone | [71] |
Endometrial | RSPO1, Noggin, Nicotinamide, EGF, FGF10, HGF, A83-01 | β-estradiol, progesterone, cAMP, PRL, hPL, HCG | [78] |
Wnt3A CM, RSPO1 CM, Noggin, Nicotinamide, EGF, FGF10, A83-01, Y-27632, SB202190, ITS, β-Estradiol | β-estradiol, progesterone | [77] | |
RSPO1, Noggin, EGF, A83-01, CHIR99021, PGE2 | β-estradiol | [79] | |
Cervical | Endocervix: Wnt3A CM, RSPO1 CM, Noggin, Nicotinamide, EGF, FGF10, SB431542, Y-27632 | – | [94] |
Ectocervix: Noggin, Nicotinamide, EGF, FGF10, SB431542, Y-27632, Forskolin, Hydrocortisone | |||
Trophoblast | RSPO1, Noggin, EGF, HGF, A83-01, CHIR99021, PGE2 | Withdrawal of RSPO1 and CHIR99021 | [100] |
RSPO1, Noggin, EGF, HGF, FGF2, A83-01, CHIR99021, Y-27632, PGE2 | Adapted from Okae 2018: 2-mercaptoethanol, BSA, ITS-X supplement, NRG1, A83-01, KOSR; after cell outgrowth (d7-10) NRG1 was omitted | [101] |